NCT03803631View on ClinicalTrials.gov

CNV in AMD Analyzed by OCT Angiography Under IntravitreaL Eylea (COCTAEyl)

CompletedOBSERVATIONAL
Enrollment

49

Participants

Timeline

Start Date

April 4, 2018

Primary Completion Date

November 15, 2021

Study Completion Date

November 15, 2021

Conditions
AMDExudative Macular Degeneration
Trial Locations (5)

33000

Hôpital Pellegrin, CHU de Bordeaux, Bordeaux

69004

Hôpital La Croix Rousse, Lyon

75010

Hôpital Lariboisière, APHP, Paris

75015

Centre Ophtalmologique d'Imagerie et de Laser,, Paris

94000

CHI de Créteil, Créteil

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Centre Hospitalier Intercommunal Creteil

OTHER

NCT03803631 - CNV in AMD Analyzed by OCT Angiography Under IntravitreaL Eylea (COCTAEyl) | Biotech Hunter | Biotech Hunter